About Roy Tanaka
Form D filings for Allevion Therapeutics from 2021 to 2024 list Roy Tanaka as director.
Roy Tanaka first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Roy Tanaka in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Roy Tanaka works with at each company, as listed on that company's latest Form D.
Allevion Therapeutics, Inc. · Form D, Mar 26, 2024
DD
Dan Dearen
Director
SM
Shinya Miike
Director
NH
Neal Hermanowicz
Executive officer
JW
Jack Wang
Director
MR
Mahmood Razavi
Director
PS
Pintoo Shah
Executive officer
RW
Randy Werneth
Director
SM
Shahram Moaddeb
Executive officer, director and promoter